Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 14Leukemia, Myeloid, Acute 13Lymphoma 12Neoplasm Metastasis 11Pancreatic Neoplasms 9Prostatic Neoplasms 8Myelodysplastic Syndromes 8Burkitt Lymphoma 8Breast Neoplasms 8Glioma 7Colorectal Neoplasms 7Sarcoma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Triple Negative Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Lymphoma, T-Cell 5Lymphoma, Non-Hodgkin 5Central Nervous System Neoplasms 5Carcinoma, Renal Cell 5Wilms Tumor 4Squamous Cell Carcinoma of Head and Neck 4Rhabdoid Tumor 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lung Neoplasms 4Histiocytosis, Langerhans-Cell 4Hepatoblastoma 4

Interventions

Rituximab 4Cladribine 2tovorafenib 1polatuzumab vedotin 1obinutuzumab 1immunotoxin HA22 1ibrutinib 1Vemurafenib 1Specimen Handling 1Prednisone 1Lenalidomide 1Famotidine 1Doxorubicin 1Diphenhydramine 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1CT-P10 1Biopsy 1Aspirin 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Biopsy × 30 days × Clear all
NCT06965114 2026-06-03

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

National Cancer Institute (NCI)

Phase 1/2 Recruiting
84 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡